Renal cell carcinomas in haemodialysis patients: Does haemodialysis duration influence pathological cell types and prognosis?

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1677-1682

  Sassa, Naoto ^a   Hattori, Ryohei ^a   Tsuzuki, Toyonori ^b   Watarai, Yoshihiko ^b   Fukatsu, Akitoshi ^c   Katsuno, Satoshi ^d   Nishikimi, Tosinori ^b   Fujita, Takashi ^e   Ohmae, Kenji ^f   Gotoh, Momokazu ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c KOMAKI CITY HOSPITAL   (Japan)

^d Okazaki City Hospital   (Japan)

^e CHUKYO HOSPITAL   (Japan)

^f Nagoya Memorial Hospital   (Japan)

Author keywords

ACDK; end stage renal disease; haemodialysis; renal cell carcinoma; renal neoplasm

Indexed keywords

ACQUIRED CYSTIC DISEASE OF KIDNEY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY POLYCYSTIC DISEASE; KIDNEY SARCOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TUMOR CLASSIFICATION;

ADULT; AGED; CARCINOMA, RENAL CELL; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; RENAL DIALYSIS; SURVIVAL RATE; TIME FACTORS;

EID: 79955643160     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq529     Document Type: Article

References (23)

1. Ishikawa I, Saito Y Shikura N et al. Ten-year prospective study on the development of renal cell carcinoma in dialysis patients. Am J Kidney Dis 1990; 16: 452-458
2. Stewart JH, Buccianti G, Agodoa L et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. JAm Soc Nephrol 2003; 14: 197-207 (Pubitemid 36026310)
3. Terasawa Y, Suzuki Y Morita M et al. Ultrasonic diagnosis ofrenal cell carcinoma in hemodialysis patients. J Urol 1994; 152: 846-851 (Pubitemid 24245948)
4. Maisonneuve P, Agodoa L, Gellert R et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999; 354: 93-99 (Pubitemid 29313142)
5. Kojima Y Takahara S, Miyake O et al. Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol 2006; 13: 1045-1048 (Pubitemid 44125674)
6. Setoguchi S, Nakazawa H, Ito F et al. Impact of the long-term duration of hemodialysis on the prognosis of dialysis patients with renal cell carcinoma. J Jap Soc Dial Ther 2007; 40: 643-647 in Japanese
7. Ishikawa I. Present status ofrenal cell carcinoma in dialysis patients: a questionnaire study in 2004 and review of past questionnaires since 1982. J Jap Soc Dial Ther 2005; 38: 1689-1700 in Japanese
8. Eble JN, Sauter G, Epstein JI et al. WHO Pathology & Genetics Tumor of the Urinary System and Male Genital Organs; IARC (Inter-national Agency for Research on Cancer; p. 10). 2004
9. Tickoo SK, dePeralta-Venturina MN, Harik LR et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141-153 (Pubitemid 43740182)
10. Rioux-Leclercq NC, Epstein JI. Renal cell carcinomawith intratumoral calcium oxalate crystal deposition in patients with acquired cystic dis-ease of the kidney Arch Pathol Lab Med 2003; 127: e89-e92
11. Truong LD, Krishnan B, Cao JT et al. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 1995; 26: 1-12
12. Chudek J, Herbers J, Wilhelm M et al. The genetics ofrenal tumors in end-stage renal failure differs from those occurring in the general population. JAm Soc Nephrol 1998; 9: 1045-1051 (Pubitemid 28264731)
13. Gronwald J, Baur A, Holtgreve-Grez H et al. Chromosomal abnor-malities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization. J Pathol 1999; 187: 308-312 (Pubitemid 29064156)
14. Hora M, Hes O, Reischig T et al. Tumours in end-stage kidney Transplant Proc 2008; 40: 3354-3358
15. Hughson MD, Bigler S, Dickman K et al. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification. Mod Pathol 1999; 12: 301-309 (Pubitemid 29133852)
16. Hughson MD, Meloni AM, Silva FG et al. Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings. Cancer Genet Cytogenet 1996; 89: 65-68 (Pubitemid 26243660)
17. Oya M, Mikami S, Mizuno R et al. C-jun activation in acquired cystic kidney disease and renal cell carcinoma. J Urol 2005; 174: 726-730 (Pubitemid 40981644)
18. Koul H, Ebisuno S, Renzulli L et al. Polarized distribution of oxala-tetransport systems in LLC-PK1 cells, a line ofrenal epithelial cells. Am J Physiol 1994; 266: 266-274
19. Scheid C, Koul H, Hill WA et al. Oxalate toxicity in LLC-PK1 cells: role of free radicals. J Urol 1996; 155: 1112-1116 (Pubitemid 26052726)
20. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic kidney disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986; 110: 592-601 (Pubitemid 16095579)
21. Ishikawa I. Uremic acquired renal cystic disease: natural history and complications. Nephron 1991; 58: 257-267
22. Lieske JC, Spargo BH, Toback FG Endocytosis of calcium oxalate crystals and proliferation of renal tubular epithelial cells in a patient with type 1 primary hyperoxaluria. J Urol 1992; 148: 1517-1519
23. Sule N, Yakupoglu U, Shen S et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol 2005; 29: 443-451 (Pubitemid 40411174)